GlassScriptPhysician profile
Justin Conrad Koerner
NPI 1245095751
$2,854.16
in general payments reported to CMS, 2019-2025
7 companies · $1,131 in 2025
The $1,131 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,723 · 2025: $1,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778 · Travel and Lodging: $906 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.63 |
| Travel and Lodging | $905.53 |
| Education | $171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,555.03 | 2024-2025 | Linq II, Selectsecure, Micra |
| Boston Scientific Corporation | $1,047.85 | 2024-2025 | Watchman Flx, Resonate El Icd Vr, Ingevity Mri |
| W. L. Gore & Associates, INC. | $143.46 | 2024 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.67 | 2025 | Lifevest |
| Abbott Laboratories | $27.41 | 2024 | Assurity |
| Lantheus Medical Imaging, INC. | $21.69 | 2024 | |
| Biotronik INC. | $19.05 | 2024 | Acticor 7 Vr-T Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Koerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.